Pfizer's abrocitinib beats blockbuster Dupixent in phase 3 eczema trial, but key questions remain Laronde banks $440M to ramp up RNA-based meds that could turn cells into protein factories Bone Therapeutics' lead program falls short in knee osteoarthritis Sponsored: Accelerating Outcomes with a Pancreatic Cancer Adaptive Platform through Collaboration and IRT Expertise SPAC backs Revelation to tackle respiratory viral infections Brain cancer biotech Ziopharm snaps up new CEO from Kuur Therapeutics Genome Medical plots growth spurt with back-to-back $60M venture raise, GeneMatters acquisition Thwarting a cancer-promoting enzyme with a 2-pronged strategy to induce cell death Industry Voices—Why the COVID-19 pandemic was a watershed moment for machine learning Roche pulls Tecentriq breast cancer nod after post-approval trial flop Children's Hospital Association asks Biden for federal support as pediatric COVID-19 cases rise Featured Story | By Nick Paul Taylor Rivals are closing in on Sanofi and Regeneron’s Dupixent. With AbbVie’s Rinvoq having already bested Dupixent in atopic dermatitis, Pfizer has now chalked up its own efficacy win over the blockbuster incumbent without sharing key details of safety data that could shape the category. read more |
| |
|---|
|
| | QIAGEN’s Biotech Grants 2021 - Open Now QIAGEN is offering young biotech companies in North America and Europe the chance to win grants worth up to $100,000 in products and instruments per region. Check your eligibility and apply by September 17, 2021. Apply Now. |
Top Stories By Amirah Al Idrus Laronde launched out of Flagship Labs this year with a lofty vision: to deliver as many as 100 new RNA medicines over the next 10 years. Now, it’s fueling that goal with a major $440 million round. The massive investment also reflects a broader interest in new RNA technologies thanks to the rapid success of two mRNA vaccines against COVID-19. read more By Amirah Al Idrus Bone Therapeutics is mulling options for its lead program after the osteoarthritis treatment failed to beat placebo or an active comparator treatment in a phase 3 study involving more than 700 patients. read more Sponsored by: Almac Group When your goal is to identify effective and ineffective treatments more quickly than traditional trials through a Complex Innovative Design, the right IRT system is crucial. read more By Nick Paul Taylor The spectrum of SPAC mergers encompasses all deal sizes. While multibillion-dollar mergers have defined the space in 2021, Revelation Biosciences is joining with Petra Acquisition to create a Nasdaq-listed company with the relatively Lilliputian enterprise value of $128 million. read more By Kyle LaHucik Kevin S. Boyle has joined cell and gene therapy biotech Ziopharm as CEO. Boyle previously led Kuur Therapeutics and his hiring was done in conjunction with two leadership promotions. read more By Andrea Park In the latest phase of its mitosis, Genome Medical took a two-pronged approach: Alongside raking in $60 million in new financing, it also made a bid for GeneMatters, a Minneapolis-based provider of virtual genetic counseling services. read more By Arlene Weintraub Cancer cells adapt to a harsh, acidic environment by spewing enzymes that neutralize the acid. Canadian researchers discovered that inhibiting one of those enzymes, Carbonic Anhydrase IX (CAIX), while simultaneously promoting a form of cancer-cell death, slows tumor growth. read more By Taha Kass-Hout Times of crisis spark innovation and creativity, as evidenced in the way organizations have come together to innovate for the greater good during the COVID-19 pandemic. We now have the opportunity to build on our learnings from the past year to apply machine learning to help address several underlying problems that plague the healthcare and life sciences communities. read more By Noah Higgins-Dunn Roche’s Tecentriq was heralded just two years ago as the first PD-1/L1 treatment to win an FDA nod in triple-negative breast cancer. Now, the Swiss pharma is pulling the approval after failing a key post-approval trial. read more By Robert King The Children's Hospital Association is directly pleading with President Joe Biden to boost federal support for facilities that are facing an influx of pediatric COVID-19 cases. read more Resources Sponsored by: Cascade Chemistry by Aceto Read four customer success stories and four success factors that helped move pharmaceutical customers of Cascade Chemistry by Aceto quickly and effectively to clinic with trial-ready APIs. Sponsored by: ConnectiveRx Topple barriers to getting patients started on therapy. Guide them with mobile. Sponsored by: Patheon by Thermo Fisher Scientific Learn how a decentralized clinical trial strategy improves patient recruitment, reduces drop-out rates, and ultimately streamlines the path to the next trial phase. Sponsored by: Patheon by Thermo Fisher Scientific Learn how to build a robust packaging strategy and the key technical considerations in packaging design and operational planning to enable rapid commercialization of pharmaceuticals. Sponsored by: Patheon by Thermo Fisher Scientific Learn how regulations are changing and key considerations for commercializing cell and gene therapies without sacrificing quality. Sponsored By: LabVantage Solutions, Inc. Uncover the real impact of “digital transformation” with practical advice to help you plan your own transformative journey to a harmonized digital ecosystem. Sponsored by: Box Read Get to Know Cloud Content Management for Life Sciences and learn how to eliminate silos across all workflows, from R&D to commercialization. Sponsored by: Catalent Learn about drug product process development challenges and risks, the difference between innovator and biosimilar drug product process development, and more during the drug product process development phase. Sponsored by: Catalent Get insights on key considerations for a successful tech transfer process for manufacturing a biologic drug product, including a case study on overcoming challenges in a process transfer for a sterile diluent. Drug Development Boot Camp® 2021 Onsite and VIRTUAL in real time November 17-18, 2021 | Register now! Pre-Boot Camp preparation is now available. The MedTech Conference 2021 September 27 - 30, 2021 DPHARM: Disruptive Innovations in Clinical Trials September 28-29, 2021 | Boston, MA w/Virtual Option Let A Digital Sherpa Uncomplicate The Path for Patients ODIN – Data Transfer Made Easy Medical Affairs Strategic Summit (MASS) September 13-15, 2021 | New Brunswick, NJ Clinical Quality Oversight Forum September 27-29, 2021 | Philadelphia, PA Diversity, Equity & Inclusion Week November 9–11, 2021 | Virtual Event Fierce Biotech Forum Boston, MA | November 16-17, 2021 | 